![](/img/cover-not-exists.png)
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Nakaoka, Yoshikazu, Isobe, Mitsuaki, Takei, Syuji, Tanaka, Yoshiya, Ishii, Tomonori, Yokota, Shumpei, Nomura, Akira, Yoshida, Seitaro, Nishimoto, NorihiroLanguage:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2017-211878
Date:
November, 2017
File:
PDF, 886 KB
english, 2017